Literature DB >> 18922881

The length of consent documents in oncological trials is doubled in twenty years.

O Berger1, B H Grønberg, K Sand, S Kaasa, J H Loge.   

Abstract

BACKGROUND: The aim of the study was to investigate whether the length of informed consent documents (ICDs) for oncological trials have increased from 1987 to 2007 and analyze the content of the ICDs.
DESIGN: In total, 87 ICDs from oncological trials approved by the Regional Committee for Medical and Health Research Ethics (REC) in the central region of Norway from 1987 to 2007 were analyzed. A list of 17 basic (fundamental medical and ethical aspects) and 30 formal (juridical aspects, financing, insurance and storage of data) content components was constructed based upon international and REC guidelines for ICDs. The number of words and presence of components were registered for all ICDs.
RESULTS: The mean length of the ICDs increased from 338 (range 276-464) words in 1987-1990 to 1087 words (range 399-2345) in 2005-2007. The number of components increased from nine to 25 during the same period. Basic components increased steadily from seven in 1987-1989 to 14 in 2005-2007 while the components concerning formalities increased substantially from two to 11.
CONCLUSIONS: The increased length of the ICDs is explained by an increased complexity of the documents and especially more information about formalities. This development increasingly demands competent readers and might prohibit truly informed consents.

Mesh:

Year:  2008        PMID: 18922881     DOI: 10.1093/annonc/mdn623

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  29 in total

1.  Legalese creates consent 'conundrum' in clinical trials.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2010-07       Impact factor: 53.440

2.  Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers.

Authors:  Nut Koonrungsesomboon; Saranyapin Potikanond; Mingkwan Na Takuathung; Wutigri Nimlamool; Juntra Karbwang
Journal:  Eur J Clin Pharmacol       Date:  2019-08-19       Impact factor: 2.953

3.  Length and complexity of US and international HIV consent forms from federal HIV network trials.

Authors:  Nancy E Kass; Lelia Chaisson; Holly A Taylor; Jennifer Lohse
Journal:  J Gen Intern Med       Date:  2011-07-06       Impact factor: 5.128

4.  Improved participants' understanding of research information in real settings using the SIDCER informed consent form: a randomized-controlled informed consent study nested with eight clinical trials.

Authors:  Nut Koonrungsesomboon; Thipaporn Tharavanij; Kittichet Phiphatpatthamaamphan; Ratha-Korn Vilaichone; Sudsayam Manuwong; Parichat Curry; Sith Siramolpiwat; Thanachai Punchaipornpon; Supakit Kanitnate; Nattapol Tammachote; Rodsarin Yamprasert; Waipoj Chanvimalueng; Ruchirat Kaewkumpai; Soiphet Netanong; Peerapong Kitipawong; Paskorn Sritipsukho; Juntra Karbwang
Journal:  Eur J Clin Pharmacol       Date:  2016-11-12       Impact factor: 2.953

5.  Evidence-Based Strategies for Shortening Informed Consent Forms in Clinical Research.

Authors:  Amy Corneli; Emily Namey; Monique P Mueller; Jenae Tharaldson; Steve Sortijas; Thomas Grey; Jeremy Sugarman
Journal:  J Empir Res Hum Res Ethics       Date:  2017-01-12       Impact factor: 1.742

6.  Moving Forward on Consent Practices in Australia.

Authors:  Rebekah E McWhirter; Lisa Eckstein
Journal:  J Bioeth Inq       Date:  2018-03-12       Impact factor: 1.352

Review 7.  Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.

Authors:  Ellen M Denzen; Martha E Burton Santibáñez; Heather Moore; Amy Foley; Iris D Gersten; Cathy Gurgol; Navneet S Majhail; Ryan Spellecy; Mary M Horowitz; Elizabeth A Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2011-07-30       Impact factor: 5.742

8.  Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.

Authors:  Ryan Spellecy; Sergey Tarima; Ellen Denzen; Heather Moore; Sunil Abhyankar; Peter Dawson; Amy Foley; Iris Gersten; Mitchell Horwitz; Lensa Idossa; Steven Joffe; Naynesh Kamani; Roberta King; Aleksandr Lazaryan; Lawrence Morris; Mary M Horowitz; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-18       Impact factor: 5.742

9.  Randomization to standard and concise informed consent forms: development of evidence-based consent practices.

Authors:  Mary E Enama; Zonghui Hu; Ingelise Gordon; Pamela Costner; Julie E Ledgerwood; Christine Grady
Journal:  Contemp Clin Trials       Date:  2012-04-20       Impact factor: 2.226

10.  Consent timing and experience: modifiable factors that may influence interest in clinical research.

Authors:  David E Gerber; Drew W Rasco; Celette Sugg Skinner; Jonathan E Dowell; Jingsheng Yan; Jennifer R Sayne; Yang Xie
Journal:  J Oncol Pract       Date:  2011-12-06       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.